Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2477467 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Apolipoprotein B (APOB) antibody
- Antibody type
- Polyclonal
- Description
- Purified
- Reactivity
- Human, Guinea Pig, Porcine
- Host
- Sheep
- Isotype
- IgG
- Vial size
- 1 mL
Submitted references Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients.
Apolipoprotein B is synthesized in selected human non-hepatic cell lines but not processed into mature lipoprotein.
Identification of two regions in apolipoprotein B100 that are exposed on the cytosolic side of the endoplasmic reticulum membrane.
Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Ikejiri A, Hirano T, Murayama S, Yoshino G, Gushiken N, Hyodo T, Taira T, Adachi M
Metabolism: clinical and experimental 2004 Sep;53(9):1113-7
Metabolism: clinical and experimental 2004 Sep;53(9):1113-7
Apolipoprotein B is synthesized in selected human non-hepatic cell lines but not processed into mature lipoprotein.
Dixon JL, Biddle J, Lo CM, Stoops JD, Li H, Sakata N, Phillips TE
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2002 May;50(5):629-40
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2002 May;50(5):629-40
Identification of two regions in apolipoprotein B100 that are exposed on the cytosolic side of the endoplasmic reticulum membrane.
Du X, Stoops JD, Mertz JR, Stanley CM, Dixon JL
The Journal of cell biology 1998 May 4;141(3):585-99
The Journal of cell biology 1998 May 4;141(3):585-99
Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R
The Journal of clinical investigation 1996 Mar 15;97(6):1535-44
The Journal of clinical investigation 1996 Mar 15;97(6):1535-44
No comments: Submit comment
No validations: Submit validation data